The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Detrimental Effects of Continued Illicit Drug Use on the Treatment of HIV-1 Infection
Abstract
OBJECTIVE: To identify the effects of substance abuse status (active, former, and never) on utilization of highly active antiretroviral therapy (HAART), medication adherence, and virologic and immunologic responses to therapy. DESIGN: Prospective cohort study of 764 HIV-1-infected patients who attended an urban HIV clinic and participated in a standardized interview. MAIN OUTCOME MEASURES: Past utilization of HAART, self-reported nonadherence with antiretroviral therapy, and changes in HIV-1 RNA level and CD4+ lymphocyte count relative to prior peak and nadir, respectively. RESULTS: Forty-four percent of active drug users failed to utilize HAART compared with 22% of former drug users and 18% of non-drug users (p <.001 for both comparisons). Among participants who were taking antiretroviral therapy when interviewed, active drug users were more likely to report medication nonadherence (34% vs. 24% of nonusers and 17% of former users), had a smaller median reduction in HIV-1 RNA from baseline (0.8 log10 copies/ml vs. 1.7 in nonusers and 1.6 in former users), and had smaller median increases in CD4+ lymphocyte count from baseline (65 cells/mm3 vs. 116 in nonusers and 122 in former users) (p <.05 for all comparisons with active users). CONCLUSIONS: Active drug use was strongly associated with underutilization of HAART, nonadherence, and inferior virologic and immunologic responses to therapy, whereas former drug users and non-drug users were similar in all outcomes. Effective strategies are needed that integrate HIV-1 and substance abuse treatments.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Statistical Aspects of the Analysis of Data From Retrospective Studies of Disease
(1959) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/22.4.719 · Cited by 14,689
Palella, F. J., Delaney, K. M., Moorman, A. C., Loveless, M. O., Fuhrer, J., Satten, G. A., Aschman, D. J., & Holmberg, S. D. (1998) · New England Journal of Medicine · doi:10.1056/nejm199803263381301 · Cited by 9,405
Adherence to Protease Inhibitor Therapy and Outcomes in Patients with HIV Infection
Paterson, D. L., Swindells, S., Mohr, J., Brester, M., Vergis, E. N., Squier, C., Wagener, M. M., & Singh, N. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-1-200007040-00004 · Cited by 3,289
A REVIEW OF GOODNESS OF FIT STATISTICS FOR USE IN THE DEVELOPMENT OF LOGISTIC REGRESSION MODELS1
LEMESHOW, S., & HOSMER, D. W. (1982) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a113284 · Cited by 1,947
Surveillance for dracunculiasis, 1981-1991.
Hopkins, D. R., & Ruiz‐Tiben, E. (1992) · PubMed · Cited by 1,110
Carpenter, C. C. J., Cooper, D. A., Fischl, M. A., Gatell, J. M., Gazzard, B. G., Hammer, S. M., Hirsch, M. S., Jacobsen, D. M., Katzenstein, D. A., Montaner, J. S. G., et al. (2000) · JAMA · doi:10.1001/jama.283.3.381 · Cited by 1,012
Ledergerber, B., Egger, M., Opravil, M., Telenti, A., Hirschel, B., Battegay, M., Vernazza, P., Sudre, P., Flepp, M., Furrer, H., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(99)01122-8 · Cited by 906
Lucas, G. M., Chaisson, R. E., & Moore, R. D. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-131-2-199907200-00002 · Cited by 843
Self-citationChanges in Plasma HIV-1 RNA and CD4+ Lymphocyte Counts and the Risk of Progression to AIDS
O'Brien, W. A., Hartigan, P. M., Martin, D., Esinhart, J., Hill, A., Benoit, S., Rubin, M., Simberkoff, M. S., & Hamilton, J. D. (1996) · New England Journal of Medicine · doi:10.1056/nejm199602153340703 · Cited by 720
Shapiro, M. F., Morton, S. C., McCaffrey, D. F., Senterfitt, J. W., Fleishman, J. A., Perlman, J. F., Athey, L. A., Keesey, J. W., Goldman, D. P., Berry, S. H., et al. (1999) · JAMA · doi:10.1001/jama.281.24.2305 · Cited by 704
Research works printed but not linked: 16
- Murri, 1999, J Acquir Immune Defic Syndr, 22, 461, 10.1097/00126334-199912150-00006 · doi:10.1097/00126334-199912150-00006
- Mocroft, 1999, J Acquir Immune Defic Syndr, 22, 369, 10.1097/00126334-199912010-00008 · doi:10.1097/00126334-199912010-00008
- Bassetti, 1999, J Acquir Immune Defic Syndr, 21, 114
- Clough, 1999, Clin Infect Dis, 29, 75, 10.1086/520185 · doi:10.1086/520185
- 1992, MMWR Morb Mortal Wkly Rep, 41, 1
- Mantel, 1959, J Natl Cancer Inst, 22, 719
- Friedland, 1999, AIDS, 13, S61
- Palmer, 1999, AIDS, 13, 661, 10.1097/00002030-199904160-00006 · doi:10.1097/00002030-199904160-00006
- Brodine, 1999, Ann Intern Med, 131, 502, 10.7326/0003-4819-131-7-199910050-00004 · doi:10.7326/0003-4819-131-7-199910050-00004
- 1999, AIDS, 13, 565, 10.1097/00002030-199904010-00005 · doi:10.1097/00002030-199904010-00005
- Markowitz, 2000, JAMA, 283, 250, 10.1001/jama.283.2.250 · doi:10.1001/jama.283.2.250
- Kaufmann, 1998, Lancet, 351, 723, 10.1016/S0140-6736(98)24010-4 · doi:10.1016/s0140-6736(98)24010-4
- Deeks, 2000, J Infect Dis, 181, 946, 10.1086/315334 · doi:10.1086/315334
- Selwyn, 1993, Public Health Rep, 108, 492
- Sorensen, 1989, J Subst Abuse Treat, 6, 87, 10.1016/0740-5472(89)90035-4 · doi:10.1016/0740-5472(89)90035-4
- Craven, 1990, J Acquir Immune Defic Syndr Hum Retrovirol, 3, S45
Cited by
Competing Risk Regression Models for Epidemiologic Data
Lau, B., Cole, S. R., & Gange, S. J. (2009) · American Journal of Epidemiology · doi:10.1093/aje/kwp107 · Cited by 1,403
Simoni, J. M., Kurth, A. E., Pearson, C. R., Pantalone, D. W., Merrill, J. O., & Frick, P. A. (2006) · AIDS and Behavior · doi:10.1007/s10461-006-9078-6 · Cited by 653
Arnsten, J. H., Demas, P. A., Grant, R. W., Gourevitch, M. N., Farzadegan, H., Howard, A. A., & Schoenbaum, E. E. (2002) · Journal of General Internal Medicine · doi:10.1007/s11606-002-0044-3 · Cited by 501
Hepatitis C and Progression of HIV Disease
Sulkowski, M. S. (2002) · JAMA · doi:10.1001/jama.288.2.199 · Cited by 445
Chander, G., Himelhoch, S., & Moore, R. D. (2006) · Drugs · doi:10.2165/00003495-200666060-00004 · Cited by 379
Self-citation
Metadata
- Authors
- Lucas, G. M., Cheever, L. W., Chaisson, R. E., & Moore, R. D.
- Venue
- Journal of Acquired Immune Deficiency Syndromes
- Published
- 2001-07
- Volume
- 27
- Issue
- 3
- Pages
- 251-259
- ISSN
- 1525-4135 (ISSN-L)
- OpenAlex
- W2080407003
- Cited by
- 350
- References
- 40
- FWCI
- 12.85
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Detrimental Effects of Continued Illicit Drug Use on the Treatment of HIV-1 Infection. https://app.cochat.ai/papers/10.1097/00042560-200107010-00006
- The paper
- Lucas, G. M., Cheever, L. W., Chaisson, R. E., & Moore, R. D. (2001). Detrimental Effects of Continued Illicit Drug Use on the Treatment of HIV-1 Infection. Journal of Acquired Immune Deficiency Syndromes. https://doi.org/10.1097/00042560-200107010-00006
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.